SII invests in IntegriMedical to advance India’s 1st needle-free tech
Pune, May 17 (IANS) Serum Institute of India (SII), the world’s largest vaccine manufacturer, on Friday announced a strategic investment in IntegriMedical to advance Needle-Free Injection System (N-FIS) technology.
With the investment, SII will acquire a 20 per cent stake in
IntegriMedical. The investment will also accelerate the development and
commercialisation of the N-FIS technology, making it more widely accessible to
patients in India and worldwide“At SII, we are constantly seeking opportunities
to invest in technologies that align with our mission to make healthcare
accessible and affordable for people worldwide.
Comments
Post a Comment